MELISSA WATERBURY: Open Payments
NPI 1598908576 · RICHLAND, WA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,398 in 91 payments from 13 companies in 2025. Trend: 2023 $916 · 2024 $1,363 · 2025 $1,398
Food & beverage: $1,200Education: $198
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 55 | $719 |
| ABBVIE INC. | 11 | $146 |
| SANOFI-AVENTIS U.S. LLC | 1 | $99 |
| LEO Pharma Inc. | 4 | $80 |
| Arcutis Biotherapeutics, Inc. | 3 | $53 |
| Lilly USA, LLC | 3 | $53 |
| UCB, Inc. | 3 | $51 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 3 | $48 |
| Incyte Corporation | 2 | $41 |
| Regeneron Healthcare Solutions, Inc. | 2 | $37 |
Products named: TREMFYA, DUPIXENT, SKYRIZI, Zoryve, TALTZ, Bimzelx, RINVOQ, OPZELURA.
Industry payments across WA — which companies pay providers there.
